Submitted by kBLASTER Team on
by MedGadget
Ekso Bionics (NASDAQ: EKSO) won FDA 510(k) clearance to offer its Ekso GT powered exoskeleton for rehabilitation of patients who suffer from partial paralysis caused by a stroke and for those with spinal cord injuries between levels T4 and L5 and T3 to C7. The device can provide varying amounts of assistance to one or both legs depending on the patient’s needs and what the rehab specialist is recommending.
As the patient makes steps, a rehabilitation specialist provides guidance, assists in maintaining the proper posture, and motivates the progress. The patient in turn relearns the proper gait and walking rhythm while letting the device support the body weight that would otherwise prevent the patient from standing up.
Save time with kBLASTER's unique result management features of sorting, My Favorites, Saved Search and Search History to quickly find your primary predicate, multiple predicates or reference devices to build a successful 510(k) clearance strategy. Save money by enabling self-service extraction of actionable insight from more than 63,000 FDA medical device 510(k) clearance summaries, plus more than 76,000 splash pages for a total of nearly 140,000 records.